VivoSim Labs (NASDAQ: VIVS) Research Report Highlights AI-Powered Drug Toxicity Platform, FDA NAM Momentum
August 20, 2026 — VivoSim Labs, Inc. (NASDAQ: VIVS) is drawing investor attention following an initiation-of-coverage research report highlighting the company’s NAMkind™ 3D human tissue models, AI-powered toxicology analytics, early…
